11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Advancing Rare Disease Therapies Through Complex Development Challenges
October 22-23, 2026 | Barcelona
Veristat is pleased to attend the Rare Diseases and Orphan Drugs conference, bringing together industry experts, researchers, and innovators focused on advancing treatments for patients with rare conditions. With small patient populations, limited natural history data, and complex regulatory pathways, rare disease development requires thoughtful strategies and specialized expertise at every stage.
We look forward to exchanging perspectives with sponsors and rare disease innovators on approaches to trial design, patient recruitment, evidence generation, and regulatory planning. Veristat brings integrated expertise across clinical development, biostatistics, and regulatory science to help sponsors address these challenges, strengthen their development strategies, and advance promising therapies toward approval.
Meet With Us
Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.
Balma Gil, Business Development Director
Jayne Hunt, Regulatory Affairs Director
Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
- Full-Service Clinical Development Solutions
- Global Regulatory Strategy & Submissions
- Clinical Operations Excellence
Schedule A Meeting
Meet with us at the International Conference on Rare Diseases and Orphan Drugs by filling out the form below.
Event Topics:
8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...